Gravity Reports First Quarter of 2018 Results and Business Updates
April 27, 2018 14:19 ET
|
GRAVITY Co., Ltd.
Seoul, Korea, April 27, 2018 (GLOBE NEWSWIRE) -- GRAVITY REPORTS FIRST QUARTER OF 2018 RESULTS AND BUSINESS UPDATES Seoul, South Korea – April 27, 2018 – GRAVITY Co., Ltd. (NasdaqCM:...
Gravity Issues a Business Update
March 07, 2018 06:20 ET
|
GRAVITY Co., Ltd.
Seoul, Korea, March 07, 2018 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqCM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games based in South Korea, today...
Gravity Reports Preliminary 4Q 2017 Results and Business Updates
February 02, 2018 06:20 ET
|
GRAVITY Co., Ltd.
Seoul, Korea, Feb. 02, 2018 (GLOBE NEWSWIRE) -- GRAVITY REPORTS PRELIMINARY 4Q 2017 RESULTS AND BUSINESS UPDATES ...
Gravity Reports Third Quarter of 2017 Results and Business Updates
October 30, 2017 06:20 ET
|
GRAVITY Co., Ltd.
Seoul, Korea, Oct. 30, 2017 (GLOBE NEWSWIRE) -- GRAVITY REPORTS THIRD QUARTER OF 2017 RESULTS AND BUSINESS UPDATES Seoul, South Korea – October 30, 2017 – GRAVITY Co., Ltd. (NasdaqCM: GRVY)...
Gravity Reports Second Quarter of 2017 Results and Business Updates
August 09, 2017 06:20 ET
|
GRAVITY Co., Ltd.
Seoul, Korea, Aug. 09, 2017 (GLOBE NEWSWIRE) -- GRAVITY REPORTS SECOND QUARTER OF 2017 RESULTS AND BUSINESS UPDATES Seoul, South Korea – August 9, 2017 – GRAVITY Co., Ltd. (NasdaqCM: GRVY)...
Great Basin Scientific Provides Business Update
June 26, 2017 07:00 ET
|
Great Basin Scientific, Inc.
New Business Pipeline exceeds $5.0 million in potential new revenue; Nearly $2.0 million in potential pipeline revenue is from Stool Bacterial Pathogens Panel, currently awaiting FDA clearance SALT...
Gravity Reports FIRST Quarter of 2017 Results and Business Update
April 28, 2017 16:00 ET
|
GRAVITY Co., Ltd.
Seoul, Korea, April 28, 2017 (GLOBE NEWSWIRE) -- ...
Galectin Therapeutics Reports 2016 Financial Results and Provides Business Update
March 28, 2017 08:30 ET
|
Galectin Therapeutics
NORCROSS, Ga., March 28, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results for...
Galectin Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update
March 21, 2017 08:30 ET
|
Galectin Therapeutics
NORCROSS, Ga., March 21, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that the Company will...
Galectin Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update
November 08, 2016 08:00 ET
|
Galectin Therapeutics
NORCROSS, Ga., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer,...